Navigation Links
Poniard Pharmaceuticals Announces $6.3 Million Financing
Date:3/15/2010

sale would be unlawful prior to registration or qualification under the securities laws of any such state.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products. For additional information please visit http://www.poniard.com.

Forward-Looking Statement

This release contains forward-looking statements describing the Company's anticipated use of proceeds from the financing, its clinical and regulatory goals and partnering strategy with respect to picoplatin and the adequacy of its current cash resources. Actual results and events may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties inherent in the Company's business, including, but not limited to, the results and timing of the Company's on-going process wit
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
2. Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conference
3. Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
4. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
5. Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
6. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
7. Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
8. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
9. Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology
10. Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer
11. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Holdings, Inc. (NYSE and SIX: ZMH) is celebrating a key milestone in ... Knee System. ,   ... introduced the NexGen knee system, with its innovative design and ... of the NexGen knee have taken place worldwide. ... the importance of design innovation and component quality for surgeons and patients ...
(Date:3/27/2015)... Quebec , March 27, 2015  Valeant Pharmaceuticals ... today the closing of its previously announced registered offering ... (the "Offering"). Pursuant to the Offering, the ... $199.00 per share, for aggregate gross proceeds of approximately ... with the U.S. Securities and Exchange Commission a final ...
(Date:3/27/2015)... , March 27, 2015  RXi ... privately-held MirImmune LLC, today announced that they ... to RXi,s novel and proprietary sd-rxRNA® technology ... immunotherapies. The collaboration has the potential to ... friendly cancer treatments that could be a ...
Breaking Medicine Technology:Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... , LEXINGTON, Ky. , Feb. 1 ... it has completed the sale of secure data and messaging provider, ... Management Technologies, Inc. (OTC Bulletin Board: WNDM) as previously announced in ... sale of Secure eHealth, VHGI has also transferred all of the ...
... , Consumers Oppose Prescription Mandate; Prefer Alternative ... , Jan. 30 Mississippians are expressing outrage ... containing pseudoephedrine (PSE) to a prescription (Rx) drug. , ... number for Mississippians to contact their legislators which within the ...
Cached Medicine Technology:VirtualHealth Technologies Completes Sale of Secure eHealth, LLC and Other Assets to Wound Management Technologies; Robert Tapales Appointed President of Secure eHealth, LLC 2VirtualHealth Technologies Completes Sale of Secure eHealth, LLC and Other Assets to Wound Management Technologies; Robert Tapales Appointed President of Secure eHealth, LLC 3VirtualHealth Technologies Completes Sale of Secure eHealth, LLC and Other Assets to Wound Management Technologies; Robert Tapales Appointed President of Secure eHealth, LLC 4Mississippians React to Rushed Pseudoephedrine Debate Raging in the State Legislature 2Mississippians React to Rushed Pseudoephedrine Debate Raging in the State Legislature 3
(Date:3/28/2015)... 2015 An article in Fortune on ... prove critical to organizations that deal with PCI (Payment ... of data security, is worsening . Using numbers ... every major category out of the twelve measured improved, ... all the craziness that has gone on in the ...
(Date:3/28/2015)... How best to treat and recover from ... medicine. While diagnostic hip injections are commonly performed for ... research presented today at the American Orthopaedic Society for ... pain relief from this diagnostic injection may not predict ... study looked to assess if the amount of pain ...
(Date:3/28/2015)... San Francisco, California (PRWEB) March 28, 2015 ... search for original 1960's Who psychedelic concert posters. The Who ... Flushing, New York on August 2, 1968. According to Hawley, ... 1969 playing many concert halls and college campuses. Perhaps the ... their performance with Jim Morrison and the Doors on August ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 The ... method of sustainable health. After 18 years of research ... including professional UFC contenders, Dr. Jon Petrick is excited ... , Just some of the immediate benefits of this ... vitality, increased levels of strength of the immune system, ...
(Date:3/28/2015)... March 28, 2015 Servpro of ... this week released a report about the link between ... asthma sufferers, and according to recent medical research, may ... According to the Environmental Protection Agency, people with sensitivity ... Breathing in mold may trigger asthma attacks for asthma ...
Breaking Medicine News(10 mins):Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3
... Now an Arizona cosmetic surgeon performs a unique procedure to harvest fat ... help women obtain shapely bodies. , ... Phoenix, AZ (PRWEB) November 6, ... to create a body you,ll love? , , ,Dr. Edgardo Zavala, a ...
... in Malibu, recently celebrated its fourth anniversary with a slew of ... current and past residents. , ... (PRWEB) November 6, ... in Malibu, recently celebrated its fourth anniversary with a slew of ...
... at least some comfort in a recent, first-of-its-kind study that ... significantly lower risk of breast cancer. Christopher I. Li, M.D., ... these findings in the November issue of Cancer Epidemiology, ... who had a history of migraines had a 30 percent ...
... age and race are among the factors that can ... after carotid-artery surgery, a UT Southwestern physician involved in ... identified 11 readily available, clinical risk factors that can ... the risks and benefits of carotid surgery for an ...
... The Global AIDS Alliance,today welcomed the election of ... "We look forward to working with President-elect Obama as ... over 5,000 people and,infects another 7,500 every day," said ... "As Colin Powell, Robert Rubin and others have recently ...
... million, Earnings per Diluted, Share of $0.32 and Contract Value of $230.6 million; ... ... 5 The Advisory Board Company,(Nasdaq: ABCO ) today announced financial results ... the quarter increased 7%,to $57.6 million, from $54.0 million in the second quarter ...
Cached Medicine News:Health News:Unsightly Fat Beautifies Body 2Health News:Unsightly Fat Beautifies Body 3Health News:Malibu Alcohol and Drug Rehab Center Celebrates Fourth Anniversary 2Health News:Migraines associated with lower risk of breast cancer 2Health News:Age, race are among factors that influence carotid-surgery success 2Health News:Global AIDS Alliance Welcomes Election of Barack Obama 2Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 2Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 3Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 4Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 5Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 6Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 7Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 8Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 9Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 10
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
... Ulti-Mist™ HME product line has the right ... to adults and from intubated patients to ... humidification for both anesthesia and critical care ... provide maximum protection for patients and staff ...
... These hygroscopic condenser humidifiers (HCH) capture ... return them in the inspired gas. Small ... provide bacteriostatic and hygroscopic benefits. Depending on ... adult or small-volume model., ,The adult ...
... capture the patient`s exhaled heat and moisture ... Small and compact, they are specially treated ... on the tidal volume requirements, select either ... adult HCH is ideal for patient tidal ...
Medicine Products: